Mosaic Family Wealth’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Mosaic Family Wealth’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10	Closed	-$1K	–	688
2018 Q2	$1K	Hold	10	–	–	﹤0.01%	668
2018 Q1	$1K	Hold	10	–	–	﹤0.01%	658
2017 Q4	$1K	Hold	10	–	–	﹤0.01%	668
2017 Q3	$1K	Buy	+10	New	+$1.08K	﹤0.01%	894

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Mosaic Family Wealth's ICPT Position: Q3 2018 in Review

Mosaic Family Wealth sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2018, closing a stake of 10 shares — an estimated $1K sold.

Mosaic Family Wealth first reported a position in ICPT in Q3 2017 and held it in 4 quarters. The position peaked at $1K in Q2 2018. 175 funds tracked by Wall St. Rank hold ICPT as of Q3 2018.

Mosaic Family Wealth reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Mosaic Family Wealth sold 10 Intercept Pharmaceuticals, Inc. shares in Q3 2018, an estimated $1K.
Mosaic Family Wealth first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 4 quarters.
Mosaic Family Wealth's Intercept Pharmaceuticals, Inc. position peaked at $1K in Q2 2018.
175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2018.

Based on Mosaic Family Wealth's 13F filing for Q3 2018, filed 14 Nov 2018.